Clinical Development and Medical Affairs

The Clinical Development and Medical Affairs team at Gilead Sciences is responsible for overseeing the planning, execution, and management of clinical trials to evaluate and advance new therapies for critical diseases. This team engages in scientific communication, ensures compliance with regulatory standards, and collaborates across functions to support the successful development and commercialization of innovative biopharmaceutical products, particularly in areas such as oncology and virology. Their efforts drive the generation of clinical evidence and inform clinical strategies, ultimately improving patient outcomes.